Patents by Inventor Megan S. Lim

Megan S. Lim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9284594
    Abstract: The present invention provides fusion proteins as biomarkers specific for chromosomal translocation-based conditions (e.g., cancer), related methods for detecting fusion protein biomarkers associated with chromosomal translocation-based conditions, related methods for quantifying amount of fusion protein expression, and related methods for diagnosing chromosomal translocation-based conditions through detection of such fusion protein biomarkers. Such fusion protein biomarkers and related methods additionally find use in research settings.
    Type: Grant
    Filed: June 27, 2014
    Date of Patent: March 15, 2016
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Kojo Elenitoba-Johnson, Delphine Rolland, Venkatesha Basrur, Kevin P. Conlon, Megan S. Lim
  • Publication number: 20150031061
    Abstract: The present invention provides fusion proteins as biomarkers specific for chromosomal translocation-based conditions (e.g., cancer), related methods for detecting fusion protein biomarkers associated with chromosomal translocation-based conditions, related methods for quantifying amount of fusion protein expression, and related methods for diagnosing chromosomal translocation-based conditions through detection of such fusion protein biomarkers. Such fusion protein biomarkers and related methods additionally find use in research settings.
    Type: Application
    Filed: June 27, 2014
    Publication date: January 29, 2015
    Inventors: Kojo Elenitoba-Johnson, Delphine Rolland, Venkatesha Basrur, Kevin P. Conlon, Megan S. Lim
  • Publication number: 20140030711
    Abstract: The present invention relates to methods and biomarkers for detection and characterization of lymphoma (e.g., splenic marginal zone lymphoma) in biological samples (e.g., tissue samples, blood samples, plasma samples, cell samples, serum samples).
    Type: Application
    Filed: June 28, 2013
    Publication date: January 30, 2014
    Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Kojo S.J. Elenitoba-Johnson, Megan S. Lim, Mark J. Kiel, Thirunavukkarasu Velusamy